Cargando…

550. Effectiveness of Remdesivir for Treatment of COVID-19 in the Outpatient Setting

BACKGROUND: Remdesivir (REM) was the first FDA-approved treatment for COVID-19. A clinical trial evaluated the effectiveness of REM for the outpatient treatment of COVID-19, showing an 87% lower risk of hospitalization and death when given within the first 7 days of infectious symptoms in confirmed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vo, Vinny P, Lu, Shu, Shah, Madiha, Nguyen, Hien
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679290/ http://dx.doi.org/10.1093/ofid/ofad500.619

Ejemplares similares

524. Assessing the Safety of an Outpatient Remdesivir Infusion Program for Patients with Severe COVID-19 in the Setting of a Pandemic Surge
por: Gee, Benjamin, et al.
Publicado: (2021)

1127. Effectiveness of Remdesivir as Treatment for COVID-19 Positive US Veterans
por: Jeyapalina, Sujee, et al.
Publicado: (2022)

544. Outpatient Remdesivir Use at a Stand Alone Children's Hospital
por: Rodriguez, Brittany, et al.
Publicado: (2023)

Remdesivir improves biomarkers associated with disease severity in COVID-19 patients treated in an outpatient setting
por: Pan, David Z., et al.
Publicado: (2023)

541. The Effect of Early Remdesivir Administration in COVID-19 Disease Progression
por: Platzer, Moritz, et al.
Publicado: (2023)

Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients
por: Gottlieb, Robert L., et al.
Publicado: (2021)

519. Early Transition to Outpatient Remdesivir Increases Patient Satisfaction while Decreasing Hospital Costs
por: Chesdachai, Supavit, et al.
Publicado: (2023)

474. Real-World Experience of the Comparative Effectiveness and Safety of Remdesivir and Combination Therapy (Remdesivir and Monoclonal Antibodies) in Immunosuppressed Patients with Mild to Moderate COVID-19: A Retrospective Single-center Study in a Community Setting
por: Hirai, Jun, et al.
Publicado: (2023)

557. Trends in Remdesivir Treatment Over the Course of the COVID-19 Pandemic
por: Xin Liao, J, et al.
Publicado: (2021)

Outpatient Treatment with Anti-Sars-Cov-2 Monoclonal Antibodies and Remdesivir for COVID19 Infections Demonstrates Encouraging Outcomes in Hematopoietic Stem Cell Transplant Recipients: A Single-Center Experience
por: Ionescu, Filip, et al.
Publicado: (2022)

524. Hepatic Safety of Remdesivir Across Phase 3 Placebo-controlled COVID-19 Studies
por: Force, Lindsey, et al.
Publicado: (2023)

72. Remdesivir vs Standard Care in Patients with Moderate covid-19
por: Marty, Francisco M, et al.
Publicado: (2020)

550. Adherence and Persistency With Modern Single vs. Multi-Tablet Antiretroviral (ARV) Regimens in First Treatment of HIV in Clinical Practice
por: Mills, Anthony, et al.
Publicado: (2018)

1.550 Anécdotas musicales /
por: Barbacci, Rodolfo
Publicado: (1964)

ACNP 60(th) Annual Meeting: Poster Abstracts P276 – P550
Publicado: (2021)

The place for remdesivir in COVID-19 treatment
por: Young, Barnaby, et al.
Publicado: (2021)

COVID-19 and hypercoagulability in the outpatient setting
por: Emert, Roger, et al.
Publicado: (2020)

Remdesivir for Outpatient Management: Time to Wait, Not to Act
por: Mohapatra, Prasanta Raghab
Publicado: (2022)

550. Bamlanivimab and Casirivimab/Imdevimab Treatment Outcomes: Results from a Large Healthcare System’s Structured Implementation Experience
por: Polk, Christopher, et al.
Publicado: (2021)

1360. Remdesivir in COVID 19 patients with kidney disease: A study on the renal function and outcomes
por: Barez, Marie Yvette, et al.
Publicado: (2023)

403. Demographics, Characteristics and Health Outcomes of US Individuals Diagnosed With COVID-19 in the Outpatient Setting
por: Gupta, Rikisha, et al.
Publicado: (2023)

Early Outpatient Treatment With Remdesivir in Patients at High Risk for Severe COVID-19: A Prospective Cohort Study
por: Rajme-López, Sandra, et al.
Publicado: (2022)

Gender Differences in Virologic Response after Antiretroviral Therapy in Treatment-naïve HIV-infected Individuals: Results from the 550 Clinic HIV Cohort Study.
por: Vega, Andrea Reyes, et al.
Publicado: (2017)

Remdesivir and COVID-19
por: Ferrara, Francesco, et al.
Publicado: (2020)

Remdesivir for COVID-19
Publicado: (2020)

Remdesivir and COVID-19
por: Glaus, Matthew J, et al.
Publicado: (2020)

Remdesivir and COVID-19
por: Wang, Lei-Yun, et al.
Publicado: (2020)

Remdesivir and COVID-19
por: Dennis, Alicia
Publicado: (2020)

Remdesivir and COVID-19
por: Edwards, Jessie K, et al.
Publicado: (2020)

1852. Rethinking Empirical Treatment for Urinary Tract Infections in the Outpatient Setting
por: Wisnik, Christopher, et al.
Publicado: (2018)

561. Safety of Remdesivir vs Standard Care in Patients with Moderate Covid-19
por: Criner, Gerard J, et al.
Publicado: (2020)

555. Utilization of Remdesivir for COVID-19 in the National Veterans Affairs Healthcare System
por: Caffrey, Aisling, et al.
Publicado: (2021)

540. Does Remdesivir Impact the Clinical Outcome of Patients with COVID 19 Infection?
por: Gunasekaran, Karthik, et al.
Publicado: (2021)

Treatment of Severe COVID-19 Infection With Remdesivir in Peritoneal Dialysis
por: Geffin, Ryan, et al.
Publicado: (2023)

LEYBOLD pump TMP "550M"
por: Brouet, M, et al.
Publicado: (1978)

38. Remdesivir Treatment in Patients Hospitalized with COVID-19: A Comparative Analysis of In-Hospital All-Cause Mortality
por: Mozaffari, Essy, et al.
Publicado: (2021)

551. Remdesivir and Tocilizumab for the Treatment of Severe COVID-19 in a Community Hospital: A Retrospective Cohort Study
por: Rodriguez-Nava, Guillermo, et al.
Publicado: (2021)

550. Carbapenem--Resistant E. coli and A. baumannii Among Catheter-Related Blood Stream Infection Patients in Egyptian ICUs
por: Elmanakhly, Arwa R, et al.
Publicado: (2019)

Pulmonary administration of remdesivir in the treatment of COVID-19
por: Rasmussen, Henrik Berg, et al.
Publicado: (2020)

Remdesivir for the Treatment of Covid-19 — Final Report
por: Beigel, John H., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_k6mvetoim5jcqjnse88shkaqah